Rocio Martin Hoyos insider trades

Open-market stock purchases and sales by Rocio Martin Hoyos, Chief Strategy Officer at Atrium Therapeutics, Inc, from SEC Form 4 filings since Apr 20, 2026.

Recent trades

DateStockTradeValue
Apr 20, 2026RNA Atrium Therapeutics, IncBought (not open market)—
Apr 20, 2026RNA Atrium Therapeutics, IncBought (not open market)—

Companies traded

  • RNA Atrium Therapeutics, Inc: other filings, last Apr 20, 2026

Get free alerts when Rocio Martin Hoyos files a new trade →